Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 4 of 144 pages ‹ First < 2 3 4 5 6 > Last ›
HSL16615
 Crigger NJ
 Just Say No
 Physician Assistants 2009 Oct 8
 
http://physician-assistant.advanceweb.com/editorial/content/editorial.aspx?cc=207949
HSL16618
 Dizikes C
 Franken bill would end company tax breaks for pharmaceutical marketing
 MinnPost.com 2009 Oct 8
 
http://www.minnpost.com/cynthiadizikes/2009/10/08/12344/franken_bill_would_end_company_tax_breaks_for_pharmaceutical_mar
HSL16600
 Vitry A
 Why the ban on prescription medicine ads is a joke
 Crikey 2009 Oct 7
 
http://www.crikey.com.au/2009/10/07/ban-on-prescription-medicine-advertising-is-a-joke/
HSL16602
 Tait N, Jack A, Croft J
 Sanofi and Teva raided in EU antitrust probe
 The Finanical Times 2009 Oct 7
 
http://www.ft.com/cms/s/0/5cd0836e-b2da-11de-b7d2-00144feab49a.html
HSL16603
 O’Reilly C, Cronin Fisk M, Feeley J
 AstraZeneca Promoted Seroquel as ‘Weight Neutral’ (Update1)
 Bloomberg.com 2009 Oct 7
 
http://www.bloomberg.com/apps/news?pid=20601102&sid=a7jcYzKvq284
HSL16604
 Poses RM
 Pfizer (in the Guise of Pharmacia) Pfound to Violate Pfraud Law, While Pfizer CEO Made Pfederal Reserve Advisor
 Health Care Renewal Blog 2009 Oct 7
 
http://hcrenewal.blogspot.com/2009/10/pfizer-in-guise-of-pharmacia-pfound-to.html
HSL16609
 Morrison T
 Are You Sure You Want Off-Label Drug Promotion Protected Under Freedom of Speech?
 BNet 2009 Oct 7
 
http://industry.bnet.com/pharma/10004679/are-you-sure-you-want-off-label-drug-promotion-protected-under-freedom-of-speech/
HSL16638
 Pozniak E
 Inform or influence
 PM Live 2009 Oct 7
 
http://www.pmlive.com/find_an_article/allarticles/categories/pr_and_med_ed/2009/october/features/inform_or_influence
HSL16597
 Antitrust: Commission confirms surprise inspections in the pharmaceutical sector
 FierceBiotech 2009 Oct 6
 
http://www.fiercebiotech.com/press-releases/antitrust-commission-confirms-surprise-inspections-pharmaceutical-sector
HSL16598
 Kanter J
 European Court Sides With Drug Companies Over Pricing Matter
 The New York Times 2009 Oct 6
 
http://www.nytimes.com/2009/10/07/business/global/07eurodrugs.html?_r=1
HSL16599
 Carroll G
 Pharma companies and social media
 Econsultancy Digital Markets Limited 2009 Oct 6
 
http://econsultancy.com/blog/4728-pharma-companies-online-talk-to-activity
HSL16617
 Thomaselli R
 Pharma Drops Search Advertising After FDA Warning
 The Advertising Age 2009 Oct 6
 
http://adage.com/article?article_id=139500
HSL16589
 Carlat D
 Eli Lilly Hires CVS Caremark to Push Cymbalta
 The Carlat Psychiatry Blog 2009 Oct 5
 
http://carlatpsychiatry.blogspot.com/2009/10/eli-lilly-hires-cvs-caremark-to.html
HSL16606
 Taylor L
 China to cut 2,300 drug prices this month
 The Pharma Times 2009 Oct 5
 
http://www.pharmatimes.com/WorldNews/article.aspx?id=16684
HSL16608
 FTC Publishes Final Guides Governing Endorsements, Testimonials
 Financial Trade Commission 2009 Oct 5
 
http://www.ftc.gov/opa/2009/10/endortest.shtm
HSL16624
 Pharmaceutical Companies Rebrand Speaker Programs to Meet Changing Political and Regulatory Landscape, Says New Study by Cutting Edge Information
 PharmaLive 2009 Oct 5
 
http://pharmalive.com/news/index.cfm?articleID=656251
HSL16574
 Thompson D
 As TV Drug Ads Increase, So Do Concerns
 MSN Health & Fitness 2009 Oct 4
 
http://healthlibrary.epnet.com/GetContent.aspx?token=9fb2c26e-5711-4909-84b8-d6aa6c1eddba&chunkiid=534996
HSL16575
 Adams M
 Interview with Elissa Ladd, creator of documentaries revealing off-label marketing deceptions of Big Pharma
 Natural News 2009 Oct 4
 
http://web.archive.org/web/20100210031935/http://www.naturalnews.com/027162_drugs_health_disease.html
HSL16614
 Indian Drug Regulators Closely Watch Ads On Oral Contraceptives - Is A Ban In The Offing Or Will The Doctor Decide?
 PharmAsia News 2009 Oct 4
 
http://pharmasianews.elsevierbi.com/cs/Satellite?c=Page&cid=1216099165884&pagename=FDCReports/Page/PageNavigatorWrapper&actionType=upsell&desturl=http://pharmasianews.elsevierbi.com/cs/Satellite?c=Page&cid=1216099165884&pagename=FDCReports/Page/PageNavigatorWrapper&autoLogin=yes&queryStr=resultpage*ArticleDetail:ArticleDetailWrapper/pii*28091005001/pubdate*20091005/qbax*3prz711cljGWQ9PJ7LlK1A==&jid=pan&pii=28091005001&pubdate=20091005
HSL16572
 Goldacre B
 The damning verdict on drug trials
 The Guardian 2009 Oct 3
 
http://www.guardian.co.uk/commentisfree/2009/oct/03/bad-science-verdict-drug-trials
HSL16569
 Federação Mundial de Anunciantes critica restrição à publicidade no país
 O Globo 2009 Oct 2
 
http://oglobo.globo.com/economia/mat/2009/10/02/federacao-mundial-de-anunciantes-critica-restricao-publicidade-no-pais-767896511.asp
HSL16571
 Parekh R
 Pfizer Puts Viagra Advertising Creative in Review
 The Advertising Age 2009 Oct 2
 
http://adage.com/agencynews/article?article_id=139434
HSL16573
 Pierson R
 UPDATE 1-Allergan says suit unrelated to U.S. Botox probe
 Reuters 2009 Oct 2
 
http://www.reuters.com/article/marketsNews/idUSN0232442220091002
HSL16579
 Gullo K, Larkin C
 Allergan Sues FDA to Market Off-Label Botox Uses (Update2)
 Bloomberg.com 2009 Oct 2
 
http://www.bloomberg.com/apps/news?pid=20601103&sid=aWfiFb74XVt4
HSL16585
 Rockoff JD
 Allergan Suit Seeks to Lift Botox Curbs
 The Wall Street Journal 2009 Oct 2
 
http://online.wsj.com/article/SB125444405169558079.html
HSL16595
 Commitment to develop NHMRC principles on Conflict of Interest
 Nation Health and Medical Research Council 2009 Oct 2
 
http://www.nhmrc.gov.au/media/media/rel09/091002-conflict-of-interest.htm
HSL16562
 Bayer Sued Over Unsupported Prostate Cancer Claims on One A Day
 Center for Science in the Public Interest 2009 Oct 1
 
http://www.cspinet.org/new/200910011.html
HSL16563
 EFSA delivers its first series of opinions on ‘general function’ health claims
 European Food Safety Authority 2009 Oct 1
 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902914361.htm
HSL16564
 Edwards J
 PhRMA's New Clinical Trial Guidelines Leave Plenty of Room for Maneuver
 BNet 2009 Oct 1
 
http://industry.bnet.com/pharma/10004556/phrmas-new-clinical-trial-guidelines-leave-plenty-of-room-for-maneuver/
HSL16565
 Know my bones goes viral on Twitter
 Pharma Marketer 2009 Oct 1
 
http://pharma-marketer.com/2009/10/01/know-my-bones-goes-viral-on-twitter/
HSL16567
 Kowalenko T et al
 Industry Relations With Emergency Medicine Graduate Medical Education Programs
 Academic Emergency Medicine 2009 Oct 1; 16:(10):1025 - 1030
 
http://www3.interscience.wiley.com/journal/122615067/abstract?CRETRY=1&SRETRY=0
HSL16568
 Chisholm CD, Gentile NT, Gerhardt RT, Hauswald M, Mycyk MB, Sinert R, Sokolove PE
 Medical Advertisements in Medical Journals: the Case Against
 Academic Emergency Medicine 2009 Oct 1; 16:(10):981 - 983
 
http://www3.interscience.wiley.com/journal/122615073/abstract
HSL16576
 Olson JE, Wright DW
 Academic Emergency Medicine Can Print Pharmaceutical Advertising While Not Compromising Its Mission or Its Integrity
 Academic Emergency Medicine 2009 Oct 1; 16:(10):978 - 981
 
http://www3.interscience.wiley.com/journal/122615070/abstract?CRETRY=1&SRETRY=0
HSL16580
 Singer N
 Bayer Labels’ Cancer-Fighting Claim Draws Suit
 The New York Times 2009 Oct 1
 
http://www.nytimes.com/2009/10/02/business/media/02bayer.html?_r=1
HSL16582
 FDA Warning Letters Caused Dramatic Decline in Sponsored Link Exposures, According to comScore
 PharmaLive 2009 Oct 1
 
http://pharmalive.com/news/index.cfm?articleID=655765
HSL16588
 Keep doctors independent; ban fees from drug makers
 The Boston Globe 2009 Oct 1
 
http://www.boston.com/bostonglobe/editorial_opinion/editorials/articles/2009/10/01/keep_doctors_independent_ban_fees_from_drug_makers/
HSL16661
 Standaert CJ, Schofferman JA, Herring SA.
 Expert opinion and controversies in musculoskeletal and sports medicine: conflict of interest.
 Arch Phys Med Rehabil 2009 Oct; 90:(10):1647-51
 
http://linkinghub.elsevier.com/retrieve/pii/S0003-9993(09)00463-8
HSL16662
 Gaddis GM, Olson JE, Wright DW.
 Academic emergency medicine can print pharmaceutical advertising while not compromising its mission or its integrity.
 Acad Emerg Med 2009 Oct; 16:(10):978-81
 
http://www3.interscience.wiley.com/journal/122615070/abstract?CRETRY=1&SRETRY=0
HSL16663
 Tsiantou V, Zavras D, Kousoulakou H, Geitona M, Kyriopoulos J.
 Generic medicines: Greek physicians' perceptions and prescribing practices.
 J Clin Pharm Ther 2009 Oct; 34:(5):547-54
 
http://www3.interscience.wiley.com/journal/122325614/abstract
HSL16958
 Simaan JA.
 Herbal medicine, what physicians need to know.
 J Med Liban 2009 Oct-Dec; 57:(4):215-7
 
http://www.ncbi.nlm.nih.gov/pubmed/20027796?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1
HSL17135
 Jelinek GA, Neate SL.
 The influence of the pharmaceutical industry in medicine.
 J Law Med 2009 Oct; 17:(2):216-23
 
http://www.ncbi.nlm.nih.gov/pubmed/19998591
HSL17197
 McMahon E, Paszti L.
 Promotion of drugs and devices at international conferences held in Canada.
 Health Law Can 2009 Oct; 30:(1):16-8
 
http://www.ncbi.nlm.nih.gov/pubmed/19994554
HSL18370
 Crock E
 Ethics of pharmaceutical company relationships with the nursing profession: No free lunch…and no more pens?
 Contemporary Nurse 2009 Oct; 33:(2):202-209
 
http://www.atypon-link.com/EMP/doi/abs/10.5555/conu.2009.33.2.202
HSL16544
 Brown R
 Dangers of battling the bulge
 ABC News: The 7:30 Report 2009 Sep 30
 
http://www.abc.net.au/news/stories/2009/09/30/2701186.htm
HSL16551
 Goldstein J
 New Pharma Guidelines: No Ghostwriting, More Public Info
 The Wall Street Journal Blog 2009 Sep 30
 
http://blogs.wsj.com/health/2009/09/30/new-pharma-guidelines-no-ghostwriting-more-public-info/
HSL16554
 Poses RM
 Intermune Executive Convicted of Fraud
 Health Care Renewal Blog 2009 Sep 30
 
http://hcrenewal.blogspot.com/2009/09/intermune-executive-convicted-of-fraud.html
HSL16556
 Value Destruction: The Cost to Companies That Engage in Deceptive Marketing
 Knowledge@Wharton 2009 Sep 30
 
http://knowledge.wharton.upenn.edu/article.cfm?articleid=2350
HSL16560
 Taylor L
 EU warns pharma of new competition probes
 Pharma Times 2009 Sep 30
 
http://www.pharmatimes.com/WorldNews/article.aspx?id=16663
HSL16561
 Comer B
 UCB turns Crohn's patients into brand advocates
 Medical Marketing & Media 2009 Sep 30
 
http://www.mmm-online.com/UCB-turns-Crohns-patients-into-brand-advocates/article/151029
HSL16566
 Increasing Patient Engagement
 Pharma Marketer 2009 Sep 30
 
http://pharma-marketer.com/2009/09/30/increasing-patient-engagement/
HSL16545
 Roner L
 The power of persuasion – a rep’s guide
 Eyeforpharma.com 2009 Sep 29
 
http://social.eyeforpharma.com/story/power-persuasion-–-rep’ s-guide
HSL16552
 Kowalczyk L
 60 doctors took speaker fees from drug giant
 The Boston Globe 2009 Sep 29
 
http://www.boston.com/news/health/articles/2009/09/29/60_doctors_took_speaker_fees_from_drug_giant/
HSL16553
 Pollack A
 Former Drug Executive Convicted of Wire Fraud
 The New York Times 2009 Sep 29
 
http://www.nytimes.com/2009/09/30/business/30drug.html?_r=1
HSL16555
 Carlat D
 The Ethics of Speakers Bureaus under the Spotlight
 The Carlat Psychiatry Blog 2009 Sep 29
 
http://carlatpsychiatry.blogspot.com/2009/09/ethics-of-speakers-bureaus-under.html
HSL16559
 O’Reilly C
 Lilly to Pay Connecticut $25.1 Million Over Zyprexa
 Bloomberg.com 2009 Sep 29
 
http://www.bloomberg.com/apps/news?pid=20601202&sid=a5IlwI8PV.T8
HSL16581
 Barbour V, Clark J, Jones S, Peiperl L, Veitch E
 Ensuring Integrity in Comparative Effectiveness Research: Accentuate the Negative
 PLoS Med 2009 Sep 29; 6:(9):
 
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000152
HSL16583
 Hopkins Tanne J
 US survey favours acknowledging medical study ghostwriters
 BMJ 2009 Sep 29; 339:
 
http://www.bmj.com/cgi/content/extract/339/sep29_3/b3986
HSL16590
 Jack A
 UK watchdog rules out action on Roche
 The Finanical Times 2009 Sep 29
 
http://www.ft.com/cms/s/0/b8869a58-ac5a-11de-a754-00144feabdc0.html?nclick_check=1
HSL16540
 Wellings H
 Drug pushers
 Today Tonight 2009 Sep 28
 
http://au.todaytonight.yahoo.com/article/6109061/consumer/drug-pushers
HSL16543
 More on Pfizer’s consumer advertising campaign “that isn’t”
 Croakey 2009 Sep 28
 
http://blogs.crikey.com.au/croakey/2009/09/28/more-on-pfizers-consumer-advertising-campaign-that-isnt/
HSL16584
 Kentucky Attorney General files suit against drug giant Merck
 Lexington Herald Ledger 2009 Sep 28
 
http://www.kentucky.com/latest_news/story/955245.html
HSL16591
 Matching pharmaceutical marketing objectives to digital strategies
 Eyeforpharma.com 2009 Sep 28
 
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=8061
HSL16594
 Taylor L
 US doctors call for tougher warnings on new drugs
 The Pharma Times 2009 Sep 28
 
http://www.pharmatimes.com/WorldNews/article.aspx?id=16648
HSL16593
 Singer N
 Top-selling birth-control pills battle new image problems
 The Seattle Times 2009 Sep 27
 
http://seattletimes.nwsource.com/html/nationworld/2009950445_yaz27.html
HSL16538
 Hundley K
 Researcher who saved countless lives takes on big pharma — and pays the price
 St Petersburg Times 2009 Sep 26
 
http://www.tampabay.com/news/health/article1039179.ece
HSL16539
 Voreacos D, Feeley J, McCarty D
 Principles on Conduct of Clinical Trials
 Bloomberg.com 2009 Sep 26
 
http://www.bloomberg.com/apps/news?pid=20601202&sid=a_mAsoOlL1CY
HSL16542
 Carroll B
 Ghosting Matilda
 Health Care Renewal Blog 2009 Sep 25
 
http://hcrenewal.blogspot.com/2009/09/ghosting-matilda.html
HSL16549
 Arnold M
 Physician's group wants new drug labeling, 2-year DTC moratorium
 Medical Marketing & Media 2009 Sep 25
 
http://www.mmm-online.com/Physicians-group-wants-new-drug-labeling-2-year-DTC-moratorium/article/149797
HSL16558
 Arnold M
 Physician's group wants new drug labeling, 2-year DTC moratorium
 Medical Marketing & Media 2009 Sep 25
 
http://www.mmm-online.com/Physicians-group-wants-new-drug-labeling-2-year-DTC-moratorium/article/149797/
HSL16570
 Mares P
 The medicines regulation headache
 National Interest : ABC Radio National 2009 Sep 25
 
http://www.abc.net.au/rn/nationalinterest/stories/2009/2696989.htm
HSL16521
 Stafford RS, Wagner TH, Lavori PW
 New, but Not Improved? Incorporating Comparative-Effectiveness Information into FDA Labeling
 NEJM 2009 Sep 24; 361:(13):1230-3
 [Epub ahead of print] August 12, 2009  doi: 10.1056/NEJMp0906490
http://healthcarereform.nejm.org/?p=1421
HSL16535
 Metherell M
 Medical companies on notice
 The Age 2009 Sep 24
 
http://www.theage.com.au/national/medical-companies-on-notice-20090923-g2oc.html
HSL16536
 Gertskis M
 Call to overhaul drug regime
 Pharmacy News 2009 Sep 24
 
http://www.pharmacynews.com.au/article/call-to-overhaul-drug-regime/499758.aspx
HSL16537
 Halbfinger DM
 F.D.A. Reveals It Fell to a Push by Lawmakers
 The New York Times 2009 Sep 24
 
http://www.nytimes.com/2009/09/25/health/policy/25knee.html?_r=1
HSL16577
 Wright J.
 Marketing disease: is osteoporosis an example of 'disease mongering'?
 Br J Nurs 2009 Sep 24-Oct; 18:(17):1064-7
 
http://www.internurse.com/cgi-bin/go.pl/library/article.cgi?uid=44163;article=BJN_18_17_1064_1067
HSL16639
 Winterhalter K, Dunn G
 Social media in healthcare communications
 PM Live 2009 Sep 24
 
http://www.pmlive.com/find_an_article/allarticles/categories/pr_and_med_ed/2009/september/features/social_media_in_healthcare_communications
HSL16831
 Lexchin J, O'Donovan O
 Prohibiting or ‘managing’ conflict of interest? A review of policies and procedures in three European drug regulation agencies
 Social Science & Medicine 2009 Sep 24; 
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4X9G8VC-2&_user=8303832&_coverDate=09/24/2009&_alid=1114653813&_rdoc=1&_fmt=high&_orig=search&_cdi=5925&_sort=r&_docanchor=&view=c&_ct=1&_acct=C000000593&_version=1&_urlVersion=0&_userid=8303832&md5=55e3d0f54e165f8c4f2281a43b85dc33
HSL16519
 Feeley J, Cronin Fisk M
 AstraZeneca Denied Drug’s Diabetes Link Years After Warning
 Bloomberg News 2009 Sep 23
 
http://www.bloomberg.com/apps/news?pid=20601103&sid=aHirLmd7UiF4
HSL16596
 Regulation on drug advertisements
 Viet Nam News 2009 Sep 23
 
http://english.vietnamnet.vn/biz/2009/09/870127/
HSL16506
 Grogan K
 GSK to reduce funding for doctor seminars
 Pharma Times 2009 Sep 22
 
http://www.pharmatimes.com/WorldNews/article.aspx?id=16620
HSL16507
 Health Industry Lobbyists Hosted at Least 130 Fundraisers for Members of Congressional Health Committees This Year
 PharmaLive 2009 Sep 22
 
http://pharmalive.com/news/index.cfm?articleID=653297
HSL16513
 Editorial
 Bad Medicine
 St Petersburg Times (Florida, USA) 2009 Sep 22
 
http://www.tampabay.com/opinion/editorials/bad-medicine/1038063
HSL16514
 Call for a review of pharmaceutical regulation
 Croakey (blog) 2009 Sep 22
 
http://blogs.crikey.com.au/croakey/2009/09/22/call-for-a-review-of-pharmaceutical-regulation/
HSL16518
 Kisiel R
 Forgetful patients to be fitted with microchips to remind them to take their pills
 Daily Mail (UK) 2009 Sep 22
 
http://www.dailymail.co.uk/health/article-1215200/Forgetful-patients-fitted-microchips-remind-pills.html
HSL16534
 Syam N
 PCT Reforms & Implications for Developing Countries
 South Centre 2009 Sep 22
 
http://www.southcentre.org/index.php?option=com_content&task=view&id=1075&Itemid=279
HSL16548
 Roner L
 KAM : Does the action match the talk in pharma?
 Eyeforpharma.com 2009 Sep 22
 
http://social.eyeforpharma.com/story/kam-does-action-match-talk-pharma
HSL16508
 Comer B
 DDMAC to discuss social media, online marketing guidelines
 Medical Marketing & Media 2009 Sep 21
 
http://www.mmm-online.com/DDMAC-to-discuss-social-media-online-marketing-guidelines/article/149349/
HSL16509
 Arnold M
 GSK swears off commercial CME providers
 Medical Marketing & Media 2009 Sep 21
 
http://www.mmm-online.com/GSK-swears-off-commercial-CME-providers/article/149377/
HSL16515
 Van Voris B, Cronin Fisk M, Feeley J
 Lilly Reaches Zyprexa Agreement With Seven States
 Bloomberg News 2009 Sep 21
 
http://www.bloomberg.com/apps/news?pid=20601202&sid=aWeB4vET2JfI
HSL16516
 Johnson LA
 GlaxoSmithKline changes doctor training policy
 Associated Press 2009 Sep 21
 
http://www.memphisdailynews.com/editorial/ArticleEmail.aspx?id=44924
HSL16532
 FDA: Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools; Notice of Public Hearing
 PharmaLive 2009 Sep 2174:(181):
 
http://pharmalive.com/news/index.cfm?articleID=653925
HSL16511
 Hill M
 Ghosts in the medical machine
 The Philadelphia Inquirer 2009 Sep 20
 
http://www.allbusiness.com/medicine-health/diseases-disorders-cardiovascular-disease/13010126-1.html
HSL16764
 Pharmaceutical flimflam: drug advertising in medical journals is a global issue
 Gossypiboma 2009 Sep 19
 
http://gossypiboma.wordpress.com/2009/09/19/pharmaceutical-flimflam-drug-advertising-in-medical-journals-is-a-global-issue/
HSL17359
 Are medical journals getting better—or worse?
 The Lancet 2009 Sep 19; 374:(9694):950
 
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61644-5/fulltext
HSL16503
 McIntosh E
 New rules of engagement
 Medical Observer 2009 Sep 18
 
http://www.medicalobserver.com.au/News/0,1734,5273,18200909.aspx
HSL16510
 Comer B
 Oncologists visit pharma sites most often, survey says
 Medical Marketing & Media 2009 Sep 18
 
http://www.mmm-online.com/Oncologists-visit-pharma-sites-most-often-survey-says/article/149262
HSL16531
 Wyeth - Premarin: Ghostwriting Documents Added to Drug Industry Document Archive
 PharmaGossip 2009 Sep 18
 
http://pharmagossip.blogspot.com/2009/09/wyeth-premarin-ghostwriting-documents.html
HSL16541
 Miller N
 Ghost writing link to medical journals
 The Age 2009 Sep 18
 
http://www.theage.com.au/national/ghost-writing-link-to-medical-journals-20090917-ftoz.html
HSL16512
 Grant B
 More regulatory science: FDA chief
 The Scientist.com News Blog 2009 Sep 17
 
http://www.the-scientist.com/templates/trackable/display/blog.jsp?type=blog&o_url=blog/display/55984&id=55984
HSL16517
 Comer B
 DDMAC lashes Allergan over Latisse website
 Medical Marketing & Media 2009 Sep 17
 
http://www.mmm-online.com/DDMAC-lashes-Allergan-over-Latisse-website/article/149134/
Page 4 of 144 pages ‹ First < 2 3 4 5 6 > Last ›
